Home › Research › Long-term cohort studies
Albuminuria and Estimated GFR as Risk Factors for Dementia in Midlife and Older Age: Findings From the ARIC Study
Scheppach JB, Coresh J, Wu A, Gottesman RF, Mosley TH, Knopman DS, Grams ME, Sharrett AR et al.. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2020-05-16
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Rationale & objective Evidence is limited on how estimated glomerular filtration rate (eGFR) and urinary albumin-creatinine ratio (UACR) relate to dementia at different ages. We evaluated eGFR and UACR in midlife and older age as risk factors for dementia. Additionally, we assessed whether the association between eGFR and dementia is altered when cystatin C and β 2 -microglobulin (B2M) levels are used for GFR estimation.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study of 9,967 participants. This ARIC Study analysis evaluated estimated glomerular filtration rate and urinary albumin-creatinine ratio in midlife and older age as risk factors for dementia. It is observational, so it cannot prove that treating kidney disease would prevent dementia.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Scheppach, J. B., Coresh, J., Wu, A., Gottesman, R. F., Mosley, T. H., Knopman, D. S., et al. (2020). Albuminuria and Estimated GFR as Risk Factors for Dementia in Midlife and Older Age: Findings From the ARIC Study. American journal of kidney diseases : the official journal of the National Kidney Foundation. https://doi.org/10.1053/j.ajkd.2020.03.015
Vancouver
Scheppach JB, Coresh J, Wu A, Gottesman RF, Mosley TH, Knopman DS, et al. Albuminuria and Estimated GFR as Risk Factors for Dementia in Midlife and Older Age: Findings From the ARIC Study. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2020. doi:10.1053/j.ajkd.2020.03.015. PMID: 32428540.
BibTeX
@article{scheppach2020-32428540,
author = {Scheppach, J. B. and Coresh, J. and Wu, A. and Gottesman, R. F. and Mosley, T. H. and Knopman, D. S. and Grams, M. E. and Sharrett, A. R. and others},
title = {{Albuminuria and Estimated GFR as Risk Factors for Dementia in Midlife and Older Age: Findings From the ARIC Study}},
journal = {American journal of kidney diseases : the official journal of the National Kidney Foundation},
year = {2020},
doi = {10.1053/j.ajkd.2020.03.015},
pmid = {32428540},
url = {https://doi.org/10.1053/j.ajkd.2020.03.015}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- We evaluated eGFR and UACR in midlife and older age as risk factors for dementia.
- Additionally, we assessed whether the association between eGFR and dementia is altered when cystatin C and β 2 -microglobulin (B2M) levels are used for GFR estimation.
- Setting & participants Two baselines from the Atherosclerosis Risk in Communities (ARIC) Study were used: visit 4 (1996-1998), including 9,967 participants 54 to 74 years old, and visit 5 (2011-2013), including 4,626 participants 70 to 90 years old.
- Participants were followed up until 2017.
Why it matters
This ARIC Study analysis evaluated estimated glomerular filtration rate and urinary albumin-creatinine ratio in midlife and older age as risk factors for dementia. It is observational, so it cannot prove that treating kidney disease would prevent dementia.
Study details
- Study designcohort study
- Participants9,967
- Evidence strengthModerate
How this study scored 57/100
Published in a peer-reviewed journal, and it is a cohort study following people over time. Scored zero for effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (American journal of kidney diseases : the official journal of the National Kidney Foundation) |
| Journal's citation record | 3 / 4 | American Journal of Kidney Diseases: journal h-index 293 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2020 — within 10 year(s) of the newest study here |
| Sample size | 3 / 4 | 9,967 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 62 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 7.8 citations a year over 8 year(s) since 2020 |
| Impact for its field and year | 3 / 6 | Cited 5.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 2 / 4 | Cited 27 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Silvia Koton: h-index 30 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | Johns Hopkins University: institution h-index 2,306 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 5 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 32428540) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 57 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Long-term cohort studies from nearby years
Also tagged “biobank”
1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.